Zoetis (ZTS) Interest Expenses (2012 - 2026)
Zoetis' (ZTS) quarterly Interest Expenses came in at $62.0 million in Q1 2026, up 14.81% year-on-year from $54.0 million in Q1 2025, and up 8.77% on a QoQ basis from $57.0 million in Q4 2025.
Zoetis (ZTS) Interest Expenses (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Interest Expenses data on file, last reported at $62.0 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 14.81% year-over-year to $62.0 million in Q1 2026; TTM through Mar 2026 was $230.0 million, a 14.81% decrease from a year earlier, with the FY2025 full-year figure at $18853.4 billion, up 6880689.78% from the prior year.
- Interest Expenses for Q1 2026 stood at $62.0 million, up from $57.0 million in the prior quarter.
- Over the last five years, Interest Expenses for ZTS reached as high as $100.0 million in Q4 2024 and fell as low as $53.0 million in Q2 2022.
- Historically, Interest Expenses has averaged $64.1 million across 5 years, with a median of $59.0 million in 2023.
- Across the five-year window, Interest Expenses surged 69.49% in 2024 and sank 43.0% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $62.0 million in 2022, then declined by 4.84% to $59.0 million in 2023, then jumped by 69.49% to $100.0 million in 2024, then tumbled by 43.0% to $57.0 million in 2025, then gained by 8.77% to $62.0 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $62.0 million in Q1 2026, $57.0 million in Q4 2025, and $58.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 258.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 57.00 Mn |
| Dec 31, 2025 | 57.00 Mn |
| Sep 30, 2025 | 58.00 Mn |
| Sep 30, 2025 | 58.00 Mn |
| Jun 30, 2025 | 53.00 Mn |
| Jun 30, 2025 | 53.00 Mn |
| Mar 31, 2025 | 54.00 Mn |
| Mar 31, 2025 | 54.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Sep 30, 2024 | 57.00 Mn |
| Sep 30, 2024 | 57.00 Mn |
| Jun 30, 2024 | 59.00 Mn |
| Jun 30, 2024 | 59.00 Mn |
| Mar 31, 2024 | 68.00 Mn |
| Mar 31, 2024 | 68.00 Mn |
| Dec 31, 2023 | 59.00 Mn |
| Dec 31, 2023 | 59.00 Mn |